Literature DB >> 23926165

Antimicrobial stewardship programs.

Kimberly D Leuthner1, Gary V Doern.   

Abstract

The development of antimicrobial agents represents one of the most significant achievements in medicine during the past century. However, the emergence of antimicrobial resistance combined with the downturn in the development of new antimicrobial agents in the pharmaceutical industry poses unanticipated challenges in the effective management of infection. The issue of how we can most effectively utilize these invaluable resources, antimicrobials, in the face of infections that are ever more difficult to treat arises. This issue serves as the fundamental basis for the concept of antimicrobial stewardship, the topic of this minireview.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23926165      PMCID: PMC3838078          DOI: 10.1128/JCM.01751-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity.

Authors:  Michelle T Hecker; David C Aron; Nilam P Patel; Meghan K Lehmann; Curtis J Donskey
Journal:  Arch Intern Med       Date:  2003-04-28

2.  Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management.

Authors:  Erik L Munson; Daniel J Diekema; Susan E Beekmann; Kimberle C Chapin; Gary V Doern
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

3.  ASHP statement on the pharmacist's role in antimicrobial stewardship and infection prevention and control.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  2010-04-01       Impact factor: 2.637

4.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

Review 5.  Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute.

Authors:  Janet F Hindler; John Stelling
Journal:  Clin Infect Dis       Date:  2007-02-08       Impact factor: 9.079

6.  Effective reporting of susceptibility test results.

Authors:  S E Sharp
Journal:  Diagn Microbiol Infect Dis       Date:  1993 Mar-Apr       Impact factor: 2.803

Review 7.  The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals.

Authors:  David L Paterson
Journal:  Clin Infect Dis       Date:  2006-01-15       Impact factor: 9.079

8.  Are laboratory-based antibiograms reliable to guide the selection of empirical antimicrobial treatment in patients with hospital-acquired infections?

Authors:  Carlos Bantar; Gabriela Alcazar; Diego Franco; Francisco Salamone; Eduardo Vesco; Teodoro Stieben; Florencia Obaid; Alejandro Fiorillo; Mariano Izaguirre; María Eugenia Oliva
Journal:  J Antimicrob Chemother       Date:  2006-10-31       Impact factor: 5.790

9.  Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory.

Authors:  J J Schentag; C H Ballow; A L Fritz; J A Paladino; J D Williams; T J Cumbo; R V Ali; V A Galletta; M B Gutfeld; M H Adelman
Journal:  Diagn Microbiol Infect Dis       Date:  1993 Mar-Apr       Impact factor: 2.803

10.  Clinical impact of rapid in vitro susceptibility testing and bacterial identification.

Authors:  G V Doern; R Vautour; M Gaudet; B Levy
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

View more
  13 in total

1.  Molecular diagnosis of sepsis: New aspects and recent developments.

Authors:  O Liesenfeld; L Lehman; K-P Hunfeld; G Kost
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

Review 2.  Clinical microbiology informatics.

Authors:  Daniel D Rhoads; Vitali Sintchenko; Carol A Rauch; Liron Pantanowitz
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 3.  Diagnostics for neonatal sepsis: current approaches and future directions.

Authors:  Pui-Ying Iroh Tam; Catherine M Bendel
Journal:  Pediatr Res       Date:  2017-06-28       Impact factor: 3.756

Review 4.  Antimicrobial stewardship in hospitals in Latin America and the Caribbean: a scoping review.

Authors:  Jennifer Hegewisch-Taylor; Anahí Dreser-Mansilla; Julián Romero-Mónico; Gabriel Levy-Hara
Journal:  Rev Panam Salud Publica       Date:  2020-09-23

5.  Antimicrobial Stewardship Programs: Comparison of a Program with Infectious Diseases Pharmacist Support to a Program with a Geographic Pharmacist Staffing Model.

Authors:  Mary T Bessesen; Andrew Ma; Daniel Clegg; Randolph V Fugit; Anthony Pepe; Matthew Bidwell Goetz; Christopher J Graber
Journal:  Hosp Pharm       Date:  2015-06

6.  Prior Authorization as a Potential Support of Patient-Centered Care.

Authors:  Leah Rand; Zackary Berger
Journal:  Patient       Date:  2018-08       Impact factor: 3.883

Review 7.  Antibiotic stewardship in the intensive care unit.

Authors:  Charles-Edouard Luyt; Nicolas Bréchot; Jean-Louis Trouillet; Jean Chastre
Journal:  Crit Care       Date:  2014-08-13       Impact factor: 9.097

8.  Towards a global definition of responsible antibiotic use: results of an international multidisciplinary consensus procedure.

Authors:  Annelie A Monnier; Barry I Eisenstein; Marlies E Hulscher; Inge C Gyssens
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

9.  A complete and multifaceted overview of antibiotic use and infection diagnosis in the intensive care unit: results from a prospective four-year registration.

Authors:  Liesbet De Bus; Bram Gadeyne; Johan Steen; Jerina Boelens; Geert Claeys; Dominique Benoit; Jan De Waele; Johan Decruyenaere; Pieter Depuydt
Journal:  Crit Care       Date:  2018-09-29       Impact factor: 9.097

10.  Steering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic Resistance.

Authors:  Daniel Nichol; Peter Jeavons; Alexander G Fletcher; Robert A Bonomo; Philip K Maini; Jerome L Paul; Robert A Gatenby; Alexander R A Anderson; Jacob G Scott
Journal:  PLoS Comput Biol       Date:  2015-09-11       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.